Vaxart Files 8-K
Ticker: VXRT · Form: 8-K · Filed: Jun 11, 2025 · CIK: 72444
| Field | Detail |
|---|---|
| Company | Vaxart, Inc. (VXRT) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, regulatory-filing
Related Tickers: VXRT
TL;DR
Vaxart filed an 8-K on 6/11/25, but it's mostly boilerplate with no new info.
AI Summary
Vaxart, Inc. filed an 8-K on June 11, 2025, reporting other events and financial statements. The filing does not contain specific financial figures or details about the 'other events' beyond its classification.
Why It Matters
This 8-K filing indicates Vaxart, Inc. has made a regulatory submission, but lacks specific details on the nature of the events or financial implications.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report with no new material information or significant financial disclosures.
Key Players & Entities
- Vaxart, Inc. (company) — Registrant
- June 11, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- South San Francisco, California (location) — Principal executive offices
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 11, 2025.
What is the exact name of the registrant?
The exact name of the registrant is Vaxart, Inc.
In which state was Vaxart, Inc. incorporated?
Vaxart, Inc. was incorporated in Delaware.
What is the address of Vaxart, Inc.'s principal executive offices?
The address of Vaxart, Inc.'s principal executive offices is 170 Harbor Way, Suite 300, South San Francisco, California 94080.
What is the Commission File Number for Vaxart, Inc.?
The Commission File Number for Vaxart, Inc. is 001-35285.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding Vaxart, Inc. (VXRT).